Literature DB >> 29263836

Erratum: Genomic landscape of high-grade meningiomas.

Wenya Linda Bi1,2,3, Malak Abedalthagafi4,5,6, Noah F Greenwald1,2,3, Jeremiah Wala2,3, Will J Gibson2,3, Pankaj K Agarwalla2,7, Peleg Horowitz8, Steven E Schumacher2,3, Ekaterina Esaulova9,10, Yu Mei1, Aaron Chevalier3, Matthew A Ducar11, Aaron R Thorner11, Paul van Hummelen11, Anat O Stemmer-Rachamimov12, Maksym Artyomov9, Ossama Al-Mefty1, Gavin P Dunn9,13,14, Sandro Santagata4, Ian F Dunn1, Rameen Beroukhim2,3,15.   

Abstract

[This corrects the article DOI: 10.1038/s41525-017-0014-7.].

Entities:  

Year:  2017        PMID： 29263836      PMCID： PMC5677977          DOI： 10.1038/s41525-017-0023-6

Source DB:  PubMed          Journal:  NPJ Genom Med        ISSN： 2056-7944            Impact factor:   8.617


Erratum to: npj Genomic Medicine (2017); doi:10.1038/s41525-017-0014-7; Published 26 April 2017 This article contained typographical errors within the Availability of data and material section: All code used for analysis is available at https://github.com/ngreenwald/publications/Lab_Stuff/High_Grade_Meningioma. Now reads: All code used for analysis is available at https://github.com/ngreenwald/Publications/tree/master/High_Grade_Meningioma. This error has now been corrected in the HTML and PDF versions of this Article.
  5 in total

1.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

2.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

3.  Mutated KLF4(K409Q) in meningioma binds STRs and activates FGF3 gene expression.

Authors:  Alla V Tsytsykova; Graham Wiley; Chuang Li; Richard C Pelikan; Lori Garman; Francis A Acquah; Blaine H M Mooers; Erdyni N Tsitsikov; Ian F Dunn
Journal:  iScience       Date:  2022-08-03

Review 4.  The Current State of Radiomics for Meningiomas: Promises and Challenges.

Authors:  Hao Gu; Xu Zhang; Paolo di Russo; Xiaochun Zhao; Tao Xu
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

5.  Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.

Authors:  Erik A Williams; Sandro Santagata; Hiroaki Wakimoto; Ganesh M Shankar; Fred G Barker; Radwa Sharaf; Abhinav Reddy; Phoebe Spear; Brian M Alexander; Jeffrey S Ross; Priscilla K Brastianos; Daniel P Cahill; Shakti H Ramkissoon; Tareq A Juratli
Journal:  Acta Neuropathol Commun       Date:  2020-10-21       Impact factor: 7.801
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.